FI961202A - Grb3-3-gen, dess varianter och deras användningar - Google Patents

Grb3-3-gen, dess varianter och deras användningar Download PDF

Info

Publication number: FI961202A
Authority: FI; Finland
Prior art keywords: grb3; variants; gene; protein; sequences
Prior art date: 1993-09-15

Application number

FI961202A

Other languages

English (en)

Finnish (fi)

Other versions

FI120499B (sv

FI961202A0 (sv

Inventor

Fabien Schweighoffer

Bruno Tocque

Original Assignee

Rhone Poulenc Rorer Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1993-09-15

Filing date

1996-03-14

Publication date

1996-03-14

1996-03-14 Application filed by Rhone Poulenc Rorer Sa filed Critical Rhone Poulenc Rorer Sa

1996-03-14 Publication of FI961202A publication Critical patent/FI961202A/sv

1996-03-14 Publication of FI961202A0 publication Critical patent/FI961202A0/sv

2009-11-13 Application granted granted Critical

2009-11-13 Publication of FI120499B publication Critical patent/FI120499B/sv

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
- C07K14/4705—Regulators; Modulating activity stimulating, promoting or activating activity
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Molecular Biology (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Gastroenterology & Hepatology (AREA)
Zoology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Toxicology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Virology (AREA)
Bioinformatics & Cheminformatics (AREA)
Communicable Diseases (AREA)
AIDS & HIV (AREA)
Tropical Medicine & Parasitology (AREA)
Engineering & Computer Science (AREA)
Oncology (AREA)
Immunology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Enzymes And Modification Thereof (AREA)
Peptides Or Proteins (AREA)

FI961202A 1993-09-15 1996-03-14 Förfaranden som anknyter till Grb3-3-gen eller dess varianter FI120499B (sv)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
FR9310971		1993-09-15
FR9310971A FR2710074B1 (fr)	1993-09-15	1993-09-15	Gène GRB3-3, ses variants et leurs utilisations.
PCT/FR1994/000542 WO1995007981A1 (fr)	1993-09-15	1994-05-09	Gene grb3-3, ses variants et leurs utilisations
FR9400542		1994-05-09

Publications (3)

Publication Number	Publication Date
FI961202A true FI961202A (sv)	1996-03-14
FI961202A0 FI961202A0 (sv)	1996-03-14
FI120499B FI120499B (sv)	2009-11-13

Family

ID=9450882

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
FI961202A FI120499B (sv)	1993-09-15	1996-03-14	Förfaranden som anknyter till Grb3-3-gen eller dess varianter

Country Status (27)

Country	Link
US (2)	US5831048A (sv)
EP (1)	EP0719328B1 (sv)
JP (1)	JP3794697B2 (sv)
KR (1)	KR100330477B1 (sv)
CN (1)	CN1098930C (sv)
AT (1)	ATE196926T1 (sv)
AU (1)	AU698819B2 (sv)
BR (1)	BR9407693A (sv)
CA (1)	CA2169938A1 (sv)
CZ (1)	CZ288882B6 (sv)
DE (1)	DE69426121T2 (sv)
DK (1)	DK0719328T3 (sv)
ES (1)	ES2152313T3 (sv)
FI (1)	FI120499B (sv)
FR (1)	FR2710074B1 (sv)
GR (1)	GR3034600T3 (sv)
HU (1)	HU221516B (sv)
IL (2)	IL126756A (sv)
NO (1)	NO319144B1 (sv)
NZ (1)	NZ266162A (sv)
PL (1)	PL178402B1 (sv)
PT (1)	PT719328E (sv)
RU (1)	RU2159815C2 (sv)
SK (1)	SK281123B6 (sv)
UA (1)	UA46715C2 (sv)
WO (1)	WO1995007981A1 (sv)
ZA (1)	ZA947059B (sv)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2732348B1 (fr) *	1995-03-31	1997-04-30	Rhone Poulenc Rorer Sa	Systeme d'expression conditionnel
US6423824B1 (en)	1995-06-07	2002-07-23	Biogen, Inc.	CAIP-like gene family
US6171800B1 (en)	1995-06-07	2001-01-09	Biogen, Inc.	Method of making and binding CAIP polypeptides
US5837844A (en) *	1995-06-07	1998-11-17	Biogen, Inc.	CAIP-like gene family
US5855911A (en) *	1995-08-29	1999-01-05	Board Of Regents, The University Of Texas System	Liposomal phosphodiester, phosphorothioate, and P-ethoxy oligonucleotides
AU6342696A (en) *	1996-06-27	1998-01-14	Biogen, Inc.	The caip-like gene family
US7309692B1 (en) *	1996-07-08	2007-12-18	Board Of Regents, The University Of Texas System	Inhibition of chronic myelogenous leukemic cell growth by liposomal-antisense oligodeoxy-nucleotides targeting to GRB2 or CRK1
US6977244B2 (en)	1996-10-04	2005-12-20	Board Of Regents, The University Of Texas Systems	Inhibition of Bcl-2 protein expression by liposomal antisense oligodeoxynucleotides
US7285288B1 (en)	1997-10-03	2007-10-23	Board Of Regents, The University Of Texas System	Inhibition of Bcl-2 protein expression by liposomal antisense oligodeoxynucleotides
US7704962B1 (en)	1997-10-03	2010-04-27	Board Of Regents, The University Of Texas System	Small oligonucleotides with anti-tumor activity
EP0998945A1 (en) *	1998-09-30	2000-05-10	Transgene S.A.	Use of magnesium (Mg2+) for the enhancement of gene delivery in gene therapy
IL151928A0 (en)	2000-03-30	2003-04-10	Whitehead Biomedical Inst	Rna sequence-specific mediators of rna interference
SI1407044T2 (en)	2000-12-01	2018-03-30	Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V.	Rna interference mediating small rna molecules
WO2003061386A1 (en) *	2002-01-03	2003-07-31	Board Of Regents, The University Of Texas System	Wt1 antisense oligos for the inhibition of breast cancer

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1992013001A1 (en)	1991-01-18	1992-08-06	New York University	A RECEPTOR TYROSINE KINASE TARGET PROTEIN cDNA CLONING METHOD AND hGRB PROTEINS
WO1994007913A1 (en) *	1992-09-25	1994-04-14	Warner-Lambert Company	Peptide antagonists of sh2 binding and therapeutic uses thereof

1993
- 1993-09-15 FR FR9310971A patent/FR2710074B1/fr not_active Expired - Fee Related
1994
- 1994-05-09 PL PL94313445A patent/PL178402B1/pl not_active IP Right Cessation
- 1994-05-09 CA CA002169938A patent/CA2169938A1/fr not_active Abandoned
- 1994-05-09 HU HU9600668A patent/HU221516B/hu not_active IP Right Cessation
- 1994-05-09 CN CN94193814A patent/CN1098930C/zh not_active Expired - Fee Related
- 1994-05-09 JP JP50901595A patent/JP3794697B2/ja not_active Expired - Fee Related
- 1994-05-09 US US08/612,857 patent/US5831048A/en not_active Ceased
- 1994-05-09 EP EP94915598A patent/EP0719328B1/fr not_active Expired - Lifetime
- 1994-05-09 NZ NZ266162A patent/NZ266162A/en not_active IP Right Cessation
- 1994-05-09 CZ CZ1996758A patent/CZ288882B6/cs not_active IP Right Cessation
- 1994-05-09 AT AT94915598T patent/ATE196926T1/de not_active IP Right Cessation
- 1994-05-09 DK DK94915598T patent/DK0719328T3/da active
- 1994-05-09 KR KR1019960701323A patent/KR100330477B1/ko not_active IP Right Cessation
- 1994-05-09 AU AU67247/94A patent/AU698819B2/en not_active Ceased
- 1994-05-09 BR BR9407693A patent/BR9407693A/pt not_active Application Discontinuation
- 1994-05-09 PT PT94915598T patent/PT719328E/pt unknown
- 1994-05-09 US US09/641,640 patent/USRE37952E1/en not_active Expired - Fee Related
- 1994-05-09 UA UA96030994A patent/UA46715C2/uk unknown
- 1994-05-09 RU RU96107888/13A patent/RU2159815C2/ru active
- 1994-05-09 WO PCT/FR1994/000542 patent/WO1995007981A1/fr active IP Right Grant
- 1994-05-09 SK SK345-96A patent/SK281123B6/sk not_active IP Right Cessation
- 1994-05-09 ES ES94915598T patent/ES2152313T3/es not_active Expired - Lifetime
- 1994-05-09 DE DE69426121T patent/DE69426121T2/de not_active Expired - Fee Related
- 1994-09-12 IL IL126756A patent/IL126756A/en not_active IP Right Cessation
- 1994-09-12 IL IL11094294A patent/IL110942A/en not_active IP Right Cessation
- 1994-09-13 ZA ZA947059A patent/ZA947059B/xx unknown
1996
- 1996-03-08 NO NO19960965A patent/NO319144B1/no not_active IP Right Cessation
- 1996-03-14 FI FI961202A patent/FI120499B/sv active IP Right Grant
2000
- 2000-10-12 GR GR20000401514T patent/GR3034600T3/el not_active IP Right Cessation

Also Published As

Publication number	Publication date
US5831048A (en)	1998-11-03
NZ266162A (en)	1997-11-24
UA46715C2 (uk)	2002-06-17
IL110942A0 (en)	1994-11-28
CN1098930C (zh)	2003-01-15
USRE37952E1 (en)	2002-12-31
PL178402B1 (pl)	2000-04-28
JP3794697B2 (ja)	2006-07-05
SK281123B6 (sk)	2000-12-11
RU2159815C2 (ru)	2000-11-27
EP0719328B1 (fr)	2000-10-11
HUT74273A (en)	1996-11-28
IL110942A (en)	2001-12-23
PT719328E (pt)	2001-02-28
NO960965D0 (no)	1996-03-08
FI120499B (sv)	2009-11-13
CZ75896A3 (en)	1996-06-12
AU6724794A (en)	1995-04-03
AU698819B2 (en)	1998-11-05
CN1133064A (zh)	1996-10-09
DK0719328T3 (da)	2000-11-13
BR9407693A (pt)	1997-02-04
HU9600668D0 (en)	1996-05-28
DE69426121D1 (de)	2000-11-16
KR100330477B1 (ko)	2002-12-02
WO1995007981A1 (fr)	1995-03-23
CA2169938A1 (fr)	1995-03-23
ATE196926T1 (de)	2000-10-15
ZA947059B (en)	1995-05-18
ES2152313T3 (es)	2001-02-01
SK34596A3 (en)	1996-07-03
EP0719328A1 (fr)	1996-07-03
DE69426121T2 (de)	2001-05-31
JPH09502357A (ja)	1997-03-11
NO319144B1 (no)	2005-06-27
IL126756A (en)	2006-06-11
FR2710074B1 (fr)	1995-12-08
FI961202A0 (sv)	1996-03-14
FR2710074A1 (fr)	1995-03-24
HU221516B (hu)	2002-11-28
NO960965L (no)	1996-03-08
CZ288882B6 (cs)	2001-09-12
PL313445A1 (en)	1996-07-08
GR3034600T3 (en)	2001-01-31

Publication	Publication Date	Title
HU9501963D0 (en)	1995-08-28	7-deazapurine modified oligonucleotides
FI962247A (sv)	1996-07-22	Nya apoptosmodulerande proteiner, DNA vilket kodar dessa proteiner samt förfarande för användning av dessa
DK289688A (da)	1988-11-29	Ekspression af proapolipoprotein a-i.
DE69833784D1 (de)	2006-05-04	Polypeptide mit aminopeptidaseaktivität und für diese kodierende nukleinsäuren
DE69840230D1 (de)	2009-01-02	Polypeptide mit prolyldipeptidylaminopeptidase-aktivität und dafür kodierende nukleinsäuren
FI961202A (sv)	1996-03-14	Grb3-3-gen, dess varianter och deras användningar
GR3034766T3 (en)	2001-02-28	Recombinant dna molecules encoding aminopeptidase enzymes and their use in the preparation of vaccines against helminth infections.
DE69535696D1 (de)	2008-03-13	Tripeptidyl-aminopeptidase
WO1995006735A3 (en)	1995-06-22	Nucleotide sequences for novel protein tyrosine phosphatases
DE69837475D1 (de)	2007-05-16	Polypeptide mit aminopeptidaseaktivität und dafür kodierende nukleinsäuren
NO983537L (no)	1998-10-02	Renset SR-p70 protein
DE69321720D1 (de)	1998-11-26	Für den interleukin-9-rezeptor kodierende nukleinsäuresequenzen bzw. dafür komplementäre nuleinsäuresequenzen
ATE215123T1 (de)	2002-04-15	Or-1, ein wais-rezeptor der nuklearen rezeptoren familie
EA199900893A1 (ru)	2001-04-23	Бактериальные плазмиды
ZA982009B (en)	1999-09-06	Isolated nucleic acid molecules encoding SSX family members and uses thereof.
DK1032683T3 (da)	2005-06-06	Polypeptider med 5-aminolevulinsyre-syntase-aktivitet og nukleinsyrer, der koder for disse
CA2419038A1 (en)	2003-02-11	Nucleic acid and protein increasing expression levels under salt stress

Legal Events

Date	Code	Title	Description
2004-11-02	PC	Transfer of assignment of patent	Owner name: AVENTIS PHARMA S.A.
2009-11-13	FG	Patent granted	Ref document number: 120499 Country of ref document: FI

Date

Code

Title

Description

2004-11-02

Transfer of assignment of patent

Owner name: AVENTIS PHARMA S.A.

2009-11-13

Patent granted

Ref document number: 120499

Country of ref document: FI